HIF1A and breast carcinoma: When breast cancer cells are exposed to tamoxifen, the expression of HIF1-α increases, which stimulates over-expression of UCA1, and thereby enhances β-catenin translocation into the nucleus, promoting the extracellular redistribution of the ER [21].